Jiangsu Sinopep-Allsino Biopharmaceutical Co.,Ltd.’s Net Profit Rose 12.8% in 2022

Jiangsu Sinopep-Allsino Biopharmaceutical Co.,Ltd. (江苏诺泰澳赛诺生物制药股份有限公司) (688076.SH) reported a net profit of 122.8 million yuan in 2022, up 12.8% year-on-year.

Meanwhile, the company posted 651.3 million yuan in revenue, up 1.2% year-on-year.

At the end of the reporting period, it had 2.5 billion yuan in total assets and 597.4 million yuan in total liabilities, with a liability-to-asset ratio of 23.7%.